Acinetobacter baumannii clonal lineages I and II harboring different carbapenem-hydrolyzing-β-lactamase genes are widespread among hospitalized burn patients in Tehran  by Mahdian, Somayeh et al.
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Summary  The  aim  of  this  study  was  to  analyze  antimicrobial  resistance  pat-
terns  and  their  encoding  genes  and  genotypic  diversity  of  Acinetobacter  baumanniibaumannii;
Lineage;
Burn;
isolated  from  burn  patients  in  Tehran,  Iran.  The  presence  of  extended-spectrum
beta-lactamase-  and  blaOXA-encoding  genes  among  37  multidrug  resistant  (MDR)  A.
baumannii  strains  isolated  from  patients  hospitalized  in  a  teaching  hospital  in  Tehran
was  evaluated.  Susceptibility  to  7  antibiotics  was  tested  by  disk  agar  diffusion  andOXA  gene
to  polymyxin  B  and  colistin  was  tested  by  E-test,  according  to  CLSI  guidelines.  All
isolates  were  then  analyzed  by  PCR  for  the  presence  of  blaIMP,  blaVIM,  blaSIM blaOXA-23,
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blaOXA-24,  and  blaOXA-58-like  carbapenemase  genes,  and  blaOXA-51-like,  blaTEM, blaSHV,
blaPER,  blaVEB,  and  blaGIM genes.  Genotyping  of  A.  baumannii  strains  was  performed
by  repetitive  sequence-based  (REP)-PCR  and  cluster  analysis  of  REP-PCR  proﬁles.  A.
baumannii  isolates  were  assigned  to  international  clones  by  multiplex  PCR  sequence
group  analysis.  Twenty-ﬁve  A.  baumannii  isolates  were  classiﬁed  as  MDR,  and  12
were  classiﬁed  as  extensively  drug  resistant.  All  isolates  were  susceptible  to  col-
istin  and  polymyxin  B.  Eighty-one  percent  of  the  isolates  was  resistant  to  imipenem
or  meropenem  and  harbored  at  least  one  or  both  of  the  blaOXA-23-like  or  blaOXA-24-like
carbapenemase  genes.  Co-existence  of  different  resistance  genes  was  found  among
carbapenem-resistant  isolates.  Multiplex  PCR  sequence  group  analysis  most  commonly
assigned  A.  baumannii  isolates  to  international  clones  I  (18/37;  48.6%)  and  II  (18/37;
48.6%).  An  alarming  increase  in  resistance  to  carbapenems  and  the  spread  of  blaOXA-23-
like  and/or  blaOXA-24-like  carbapenemase  genes  was  observed  among  A.  baumannii
strains  belonging  to  clonal  lineages  I  and  II,  isolated  from  burn  patients  in  Tehran.
©  2015  King  Saud  Bin  Abdulaziz  University  for  Health  Sciences.  Published  by  Elsevier
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lates were  retrospectively  collected  from  patient
charts and  diagnostic  microbiological  laboratory
culture reports.  We  used  the  criteria  for  diagnosis
of infections  in  burn  units  described  by  Santucci  andLimited.  All  rights  reserv
Introduction
Acinetobacter  baumannii  is  a  gram-negative  bac-
terium causing  hospital-acquired  infections  in
critically  ill  patients  [1]. The  spread  of  a  restricted
number of  clonal  lineages  that  have  been  selected
because of  their  multiple  drug  resistance  has  been
reported  worldwide  [1—4].
Antimicrobial  resistance  owing  to  enzymatic
degradation,  modiﬁcation  of  targets,  and  active
efﬂux  of  drugs,  together  with  persistence  of
the bacterium  in  contaminated  environments  are
responsible  for  epidemics  of  A.  baumannii  in  hospi-
tal settings  [1,2,5,6].  Carbapenems  are  considered
the ﬁrst-line  drugs  for  treatment  of  A.  bauman-
nii infections  in  Iran;  however,  resistance  to  these
drugs is  increasing  owing  to  the  overexpression  of
efﬂux pumps  and  to  the  ability  of  the  bacterium
to produce  different  carbapenemases,  in  particular
class  D  carbapenemases  [1,2,5,6]. A.  baumannii  is
increasingly causing  infections  in  burn  units  world-
wide including  Iran  [7—9].  In  addition,  A.  baumannii
strains resistant  to  different  classes  of  antibiotics
including carbapenems  have  reportedly  been  iso-
lated from  burn  patients  in  Iran  [8,9].  The  alarming
increase in  resistance  to  carbapenems  in  Iranian
burn units  from  2001  to  2009  [8,9]  prompted  us
to analyze  whether  carbapenem  resistance  in  A.
baumannii  strains  isolated  from  burn  patients  was
caused by  horizontal  gene  transfer  or  selection  of
carbapenem-resistant  epidemic  clones,  which  has
not been  investigated  to  date.  Previous  studies  in
different  clinical  settings  have  shown  the  spread
c
w
nf  A.  baumannii  isolates  belonging  to  different
epetitive sequence-based  (REP)-PCR  proﬁles  and
nternational  clones  I  and  II  in  Iran  [10—12]. The
im of  this  study  was  to  analyze  the  antimicro-
ial resistance  patterns,  -lactamase  gene  content,
enotypic  diversity,  and  clonal  lineage  distribution
f A.  baumannii  isolates  in  a burn  ward  of  a univer-
ity teaching  hospital  in  Tehran,  Iran.
aterial and methods
tudy population
n  total,  37  non-replicate  A.  baumannii  isolates
ssociated with  infection  in  patients  admitted  to
he burn  ward  of  a teaching  hospital  in  Tehran
ere selected  for  this  study.  The  Motahari  Burn
nd Reconstruction  Center  is  one  of  the  few  large,
ighly  equipped,  tertiary  burn  centers  in  Iran,  pro-
iding care  to  severely  burned  patients  from  the
rovince  of  Tehran  and  to  those  with  complications
hat have  been  referred  from  other  centers  across
he country.  All  patients  were  admitted  immedi-
tely after  burn  injuries,  except  for  referral  cases.
Available  epidemiological  data  from  these  iso-olleagues  [13].  In  addition,  the  following  criteria
ere adopted  to  deﬁne  wound  infection  or  colo-
ization: bacteria  in  the  wound  and  wound  eschar
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R.  baumannii  clonal  lineages  in  burn  patients  
t  high  concentration  (>105 bacteria/g  tissue)  and
o invasive  infection  was  considered  as  infection;
ow concentration  of  bacteria  in  the  wound  (<105
acteria/g  tissue)  and  no  invasive  infection  was
onsidered  as  colonization  [14].
All  isolates  were  identiﬁed  as  A.  baumannii  by
PI 20NE  and  gyrB  multiplex  PCR,  as  previously
escribed [15].  A.  baumannii  strains  were  consid-
red multidrug  resistant  (MDR)  and  extensively  drug
esistant (XDR)  if  they  were  resistant  to  ≥1  agent
n ≥3  antimicrobial  categories  and  resistant  to  ≥1
gent in  all  but  ≤2  categories,  respectively,  accord-
ng to  Magiorakos  et  al.  [4].
Because we  performed  a  retrospective  study,  no
ttempts  were  made  to  recover  Acinetobacter  spp.
rom the  hospital  environment.
ntimicrobial susceptibility testing
usceptibility  to  imipenem  (10  g),  meropenem
10 g),  gentamicin  (10  g),  cefepime  (30  g),
iproﬂoxacin (5  g),  piperacillin—tazobactam
100/10 g),  and  amoxicillin-sulbactam  (10/10  g)
as evaluated  by  disk  agar  diffusion,  and  suscep-
ibility  to  polymyxin  B  and  colistin  was  evaluated
y the  E-test  method  (AB  BIODISK,  Solna,  Sweden).
esults were  interpreted  according  to  CLSI  guide-
ines [16].  Escherichia  coli  ATCC  25922  and  35218
nd Pseudomonas  aeruginosa  ATCC  27853  were
sed as  controls.
haracterization of -lactamase genes
ll  isolates  were  analyzed  by  PCR  for  detection
f blaOXA-like  carbapenemase,  extended-spectrum
eta-lactamase,  and  metallo--lactamase,  with
he speciﬁc  primers  listed  in  Supplementary  Table  1
15,17—20].  Chromosomal  DNA  was  extracted  using
 genomic  DNA  puriﬁcation  kit  (Bioneer,  Seoul,
orea). PCR  was  performed  in  a  ﬁnal  volume  of
5 L  containing  1×  PCR  buffer,  2.5  mm  MgCl2,
.2 mM  dNTP  mix,  10  pmol  of  each  primer,  and  50  ng
f template  DNA.  The  ampliﬁcation  reactions  were
erformed  at  94 ◦C  for  5  min,  followed  by  30  cycles
f denaturation  30  s  at  94 ◦C,  30  s  of  annealing  (the
ifferent  temperature  of  which  are  listed  in  Sup-
lementary  Table  1),  and  of  extension  60  s  at  72 ◦C.
. baumannii  NCTC12156,  NCTC13302,  NCTC13303,
nd NCTC13304  were  used  as  standard  positive
ontrols for  blaOXA-51,  blaOXA-23, blaOXA-24, and
laOXA-58-like  carbapenemases,  respectively.  For  all
ther PCR  ampliﬁcations,  the  products  obtained
ere considered  positive  based  on  amplicon  size
nd direct  sequencing  of  selected  amplicons.  In  the
ase of  negative  PCR,  in  which  a  positive  control
A
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as  not  used,  PCR  ampliﬁcations  were  repeated  at
east twice  for  these  genes.  A  negative  control  was
un with  every  PCR.
Supplementary  Table  1 related  to  this  arti-
le can  be  found,  in  the  online  version,  at
ttp://dx.doi.org/10.1016/j.jiph.2015.04.030.
EP-PCR typing
ll  the  isolates  were  analyzed  by  the  REP-PCR
yping method  to  ﬁnd  common  REP-types
mong all  isolates  according  to  a  previous
eport [21]. The  primers  used  for  REP-typing
ere F:  5′- IIIGCGCCGICATCAGGC-3′ and  R:  5′-
CGTCTTATCAGGCCTAC-  3′. Cluster  analysis  of
EP-PCR  proﬁles  was  performed  using  GelCompar
I v. 3.5  (Applied  Maths,  Sint-Martens-Latem,
elgium)  with  the  unweighted  pair-group  method
ith  arithmetic  mean  (UPGMA).  The  Dice  corre-
ation  coefﬁcient  was  used  with  a tolerance  of
.5% to  analyze  similarities  between  the  banding
atterns.
CR-based sequence group typing
wo  multiplex  PCRs,  designed  to  selectively  amplify
lleles of  ompA,  csuE,  and  blaOXA-51-like  genes  with
he speciﬁc  primers  listed  in  Supplementary  Table
, were  used  to  assign  the  sequence  groups  and
he corresponding  major  international  clones  I—III
ccording  to  Turton  et  al.  [3].  PCR  conditions  were
s follows:  denaturation  at  94 ◦C  for  3  min,  followed
y 30  cycles  of  94 ◦C  for  45  s,  57 ◦C  for  45  s,  72 ◦C
or 1 min,  and  a  ﬁnal  extension  at  72 ◦C  for  5 min.
roups 1,  2,  and  3  were  identiﬁed  according  to  Tur-
on et  al.  [3].
Supplementary  Table  2 related  to  this  arti-
le can  be  found,  in  the  online  version,  at
ttp://dx.doi.org/10.1016/j.jiph.2015.04.030.
tatistical analysis
ecause  of  the  limited  number  of  samples,  the
isher’s  Exact  Test  was  employed  to  assess  the
orrelation  between  antibiotic  resistance  and  the
elevant encoding  genes.  In  order  to  estimate  the
-value and  its  conﬁdence  interval,  the  Monte  Carlo
ethod  was  used.  The  data  were  analyzed  using  R
oftware version  2.1.1.
esults.  baumannii  strains  were  recovered  from  burn
ard.  The  origin  of  the  isolates  was  wounds  (30  out
f 37;  81.1%),  blood  (6  out  of  37;  16.2%),  or  urine
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Table  1  Epidemiologic  data  and  distribution  of  resistance  phenotypes  and  genes  among  international  clones  of  MDR  and  XDR  A.  baumannii  strains.
Strain  Gender  Infection  type  Source  of  isolation  MDR/XDR  ˇ-Lactamase  genes  Resistance  or  susceptible  phenotypes
blaTEM blaPER blaOXA-23 blaOXA-24 IMP  MER  GM  TET  PTZ  AMS
1  Female  Wound  infection  Wound  swab  XDR  +  +  +  −  R  R  R  R  R  R
2  Male  Bloodstream  infection  Blood  culture  XDR  +  +  +  +  I  R  R  R  R  R
3  Female  Wound  infection  Wound  swab  MDR  +  +  +  +  R  I  R  R  R  S
4  Female  Wound  infection  Wound  swab  MDR  −  +  +  −  R  R  R  R  S  S
5  Male  Wound  infection  Wound  swab  XDR  −  +  +  +  R  R  R  R  R  I
6  Female  Wound  infection Wound  swab MDR  −  +  +  −  R  R  R  R  R  S
7  Female  Wound  infection Wound  swab XDR  −  +  +  −  R  R  R  R  R  R
8  Male  Bloodstream  infection Blood  culture MDR  −  +  +  +  R  R  R  R  R  S
9  Male  Wound  infection Wound  swab MDR  −  +  +  +  R  R  R  R  R  S
10  Male  Wound  infection Wound  swab MDR  −  +  +  −  R  R  R  S  R  S
11  Male  Wound  infection Wound  swab MDR  +  +  +  +  R  R  R  R  R  R
12  Male  Wound  infection  Wound  swab  MDR  +  +  +  −  R  R  S  R  R  R
13  Female  Wound  infection  Wound  swab  XDR  −  +  +  −  R  R  R  R  R  I
14  Female  Bloodstream  infection  Blood  culture  XDR  −  +  +  +  R  R  R  R  R  R
15  Female  Wound  infection  Wound  swab  XDR  −  +  +  +  R  R  R  R  R  I
16  Male  Bloodstream  infection  Blood  culture  XDR  −  +  +  −  R  R  R  R  R  R
17  Male  Wound  infection  Wound  swab  XDR  +  +  +  +  R  R  R  R  R  R
18  Male  Wound  infection  Wound  swab  XDR  +  +  +  −  R  R  R  R  R  R
19  Female  Bloodstream  infection  Blood  culture  XDR  −  +  +  +  R  R  R  R  R  R
20  Female  Bloodstream  infection  Blood  culture  MDR  +  +  +  −  R  R  R  R  R  S
21  Male  Wound  infectionn  Wound  swab  XDR  −  +  +  −  R  R  R  R  R  R
22  Female  Wound  infection  Wound  swab  MDR  +  +  +  +  R  R  R  R  R  R
23  Male  Wound  infection  Wound  swab  MDR  +  +  +  +  R  R  R  I  R  S
24  Female  Wound  infection  Wound  swab  MDR  +  +  +  −  R  R  R  R  R  S
25  Male  Wound  infection  Wound  swab  MDR  +  +  −  +  S  I  R  R  R  R
26  Female  Wound  infection  Wound  swab  MDR  +  +  −  +  S  I  R  R  R  R
27  Male  Wound  infection  Wound  swab  MDR  −  +  −  +  S  I  R  I  I  I
28  Male  Wound  infection  Wound  swab  MDR  −  +  −  +  S  R  R  R  R  R
29  Male  Wound  infection  Wound  swab  MDR  −  +  +  −  S  R  R  R  R  R
30  Female  Urinary  tract  infection Urine  culture MDR  −  +  +  +  S  R  R  R  R  I
31  Female  Wound  infection Wound  swab MDR  −  −  −  −  S  S R  R  S  S
32  Female  Wound  infection Wound  swab  MDR  −  −  −  −  S  S I  R  S  R
33  Male  Wound  infection  Wound  swab  MDR  −  −  −  −  S  S R  S  S  R
34  Male  Wound  infection  Wound  swab  MDR  −  −  −  −  S  S I  I  R  R
35  Male  Wound  infection  Wound  swab  MDR  −  −  −  −  S  S S  I  R  R
A.  baumannii  clonal  lineages  in  burn  patients  
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1  out  of  37;  2.7%)  and  were  associated  with  wound
nfections,  bloodstream  infections,  or  urinary  tract
nfection,  respectively  (Table  1).
Genotyping  of  A.  baumannii  isolates  identiﬁed  11
ifferent REP-PCR  types  that  we  labeled  A  through
, which  showed  a  similarity  of  <80%  in  dendro-
ram analysis  (Fig.  1).  REP-PCR  types  I  (11/37;
9.7%), E  (8/37;  21.6%),  B  (3/37;  8.1%),  and  J  (3/37;
.1%) were  the  most  frequently  isolated  (Fig.  1  and
able  1). The  majority  of  isolates  belonged  to  either
nternational  clone  I  (48.6%;  18  out  of  37)  or  II
48.6%;  18  out  of  37).  Only  one  isolate  belonged
o international  clone  III  (2.7%;  1 out  of  37)  (Fig.  1
nd  Table  1).
Antimicrobial  susceptibility  studies  showed  that
6 (70.3%)  and  37  (29.7%)  of  the  A.  baumannii
solates were  MDR  and  XDR,  respectively  (Table  1).
one was  resistant  to  colistin  or  polymyxin  B
MIC ranges  of  both  were  0.12—0.5  g/mL;  MIC50
.25  g/mL  and  MIC90 0.5  g/mL).  The  highest
esistance rate  was  observed  against  ciproﬂoxacin
nd cefepime  (100%),  followed  by  gentami-
in (94.6%),  piperacillin—tazobactam  (86.5%),
eropenem (81.1%),  ampicillin-sulbactam  (73%),
nd imipenem  (64.9%).  Sixteen  of  the  30  isolates
53.3%) resistant  to  meropenem  and  13  of  the  24
solates  (54.1%)  resistant  to  imipenem  belonged
o sequence  group  1,  corresponding  to  interna-
ional clone  II.  Correlations  between  antimicrobial
usceptibilities,  REP-PCR  types,  and  international
lones are  shown  in  Table  2. Chi-squared  and
isher exact  tests  showed  no  signiﬁcant  correlation
etween imipenem  and  meropenem  resistance
nd MDR,  XDR,  REP-types,  and  the  presence
f blaOXA-24-like  (p  >  0.05);  however,  there  was
 signiﬁcant  difference  between  resistance  to
mipenem  and  meropenem  and  the  presence  of
laOXA-23-like  carbapenemase  (p  ≤  0.05).
All isolates  harbored  the  blaOXA-51-like  beta-
actamase intrinsic  to  A.  baumannii  isolates.
ighty-one percent  of  cefepime-resistant  iso-
ates (30  out  of  37)  harbored  the  blaPER-like
ene (Table  1). The  distribution  of  blaTEM-
ike in  cefepime-resistant  isolates  was  35.1%
13 out  of  37)  (Table  1).  All  imipenem-  and
eropenem-resistant  isolates  contained  at  least
ne blaOXA-23 and/or  blaOXA-24-like  carbapenemase.
ll imipenem-resistant  and  86.7%  of  meropenem-
esistant (26  out  of  30)  isolates  harbored  a
laOXA-23-like  gene  ﬂanked  by  ISAba1  at  the  5′end
f the  gene;  56.7%  (17  out  of  30)  of  meropenem-
esistant and  50%  (12  out  of  24)  of  imipenem-
esistant isolates  contained  the  blaOXA-24-like  gene.
he coexistence  of  blaOXA-23/blaOXA-24 was  seen
n 50%  (12  out  of  24)  and  43.3%  (13  out  of  30)
f imipenem-resistant  and  meropenem-resistant
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Figure  1  Cluster  analysis  of  REP-PCR  proﬁles  of  the  A.  baumannii  strains  isolated  from  burn  patients.  Strain  number,
REP-PCR  proﬁles,  and  international  clone  assignments  are  indicated.
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solates,  respectively.  We  could  not  detect  any
laOXA-58-like,  blaOXA-143, blaVEB-like,  blaIMP-like,
laVIM-like,  blaSIM-like,  blaGIM-like,  or blaSHV-
ike genes.  ISAba1,  upstream  of  and  adjacent
o blaOXA-51-like  and  blaOXA-23-like  genes,  was
etected among  all  carbapenem-resistant  isolates
arrying  these  genes  (30  out  of  37;  81.1%).  We
id not  detect  IS1133 upstream  of  blaOXA-51-like  and
laOXA-23-like  genes.
iscussion
lthough  carbapenems,  aminoglycosides,  and  ﬂuo-
oquinolones  have  been  used  to  treat  A.  baumannii
nfections in  different  medical  settings,  resistance
o carbapenems  has  been  increasing  in  Iran  and  in
ther countries  [1,9—12]. The  results  of  this  study
how that  resistance  to  different  antibiotics  includ-
ng carbapenems  was  high  in  A.  baumannii  isolated
rom  burn  patients  in  Tehran.  In  this  study,  only
olistin  and  polymyxin  B  were  active  against  all
. baumannii  strains.  This  is  concerning  because
hese drugs  have  nephrotoxic  and  neurotoxic  side
ffects [22,23]. Resistance  rates  to  imipenem  in
ehran hospitals  increased  alarmingly  from  40.47%
n 2008  to  48.9%  in  2012  and  to  59%  in  2013
9—11]. Trend  analysis  using  the  Chi-squared  test
howed that  there  is  a statistically  signiﬁcant  linear
rend between  resistances  to  imipenem  in  different
ears (p  ≤  0.03).  Concordantly,  64.9%  of  A.  bau-
annii  strains  isolated  from  burn  patients  during
011 described  in  the  present  study  was  resistant
o imipenem.  Resistance  rates  to  imipenem  and
eropenem  were  64.9%  and  81.1%,  respectively.  In
 previous  study  performed  at  this  teaching  hospi-
al, resistance  to  imipenem  was  57.3%  [9], which
as lower  than  that  observed  in  the  present  study.
ecent studies  reported  high  rates  of  resistance
o carbapenems  in  hospital  settings  in  Tehran  and
abriz [10,11]. The  increase  in  carbapenem  resis-
ance in  A.  baumannii  strains  isolated  from  burn
atients  in  Iran  can  jeopardize  treatment  with  car-
apenems.
Mounting  evidence  indicates  that  production  of
arbapenemases  belonging  to  class  D  -lactamase
s the  most  important  mechanism  for  carbapenem
esistance in  A.  baumannii  isolates  from  Iran
8—11]. In  accordance  with  previous  studies
24—26],  A.  baumannii  strains  included  in  our  study
ere resistant  to  imipenem  or  meropenem  and  con-
ained blaOXA-23-like,  blaOXA-24-like,  blaOXA-51-like
enes, and/or  combinations  of  these  genes.  Our
ata are  also  in  agreement  with  those  of  previous
tudies showing  that  ISAba1 provides  the  promoter
equired for  expression  of  adjacent  blaOXA-51 and
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blaOXA-23 genes  [24,25]. In  fact,  we  also  found
ISAba1 upstream  of  and  adjacent  to  blaOXA-51-like
and blaOXA-23-like  genes  in  all  carbapenem-resistant
isolates  carrying  these  genes.  Other  -lactams  such
as metallo--lactamase  blaIMP and  blaVIM have  been
reported sporadically  in  A.  baumannii  isolates  from
Iran [8]  and  from  Tabriz  province  [11], but  not  from
the A.  baumannii  isolates  from  Tehran  described
herein and  in  a  previous  study  [9].  Based  on  the
data shown  herein,  we  can  postulate  that  car-
bapenem  resistance  in  A.  baumannii  strains  isolated
from burn  patients  in  Tehran  was  selected  by  the
spread  of  blaOXA-23-like,  blaOXA-24-like,  or  blaOXA-51-
like genes.  Our  data  identiﬁed  a  restricted  number
of REP-PCR  genotypes  with  REP-PCR  types  E and  I
occurring in  A.  baumannii  strains  isolated  from  8
and 11  patients,  respectively.  Owing  to  the  lack  of
sufﬁcient molecular  epidemiology  data  regarding
clonal circulation  of  drug-resistant  A.  baumannii
in this  hospital,  we  cannot  deﬁnitively  comment
on the  clonal  circulation  of  MDR  and  XDR  A.  bau-
mannii; however,  according  to  the  results  of  this
study and  those  of  Bahador  et  al.,  it  seems  that
the spread  of  MDR  and  XDR  A.  baumannii  strains
among burn  patients  in  Iran  may  be  mostly  due
to cross-transmission  of  a  few  predominant  geno-
types  between  patients.  Identiﬁcation  of  three
concurrent  MDR  international  clonal  lineages  (I—III)
among A.  baumannii  strains  isolated  from  burn
patients  in  Tehran  is  noteworthy.  These  resistant
clones were  ﬁrst  reported  from  European  hospitals.
However, they  quickly  spread  to  other  hospitals
worldwide and  were  then  considered  international
clones [2].  The  incidence  of  MDR  A.  baumannii  is
increasing  worldwide;  carbapenem  could  become
an important  selector  for  MDR  and  XDR  A.  bauman-
nii. Therapeutic  options  for  treating  infections  with
these bacteria  are  becoming  increasingly  limited.
[27,28].
Our data  show  that  international  clones  1 and
II, producing  blaOXA-23-like  and  blaOXA-24-like  car-
bapenemases,  are  predominant  among  the  A.
baumannii  strains  isolated  from  burn  patients  in
Tehran [10].  The  spread  of  carbapenem-resistant
A. baumannii  clonal  lineages  I  and  II  producing
blaOXA-23-like  and  blaOXA-24-like  carbapenemases
has been  observed  in  Europe,  Asia,  and  Latin  Amer-
ica [2,29,30].  Our  data  are  in  agreement  with  those
of two  studies  from  Tehran  and  Tabriz  reporting
the spread  of  international  clones  I and  II  in  Iran
[10,11].  In  the  present  study,  one  strain  belong-
ing to  international  clone  III  was  isolated  for  the
ﬁrst time  from  burn  wound  infections.  Interest-
ingly, A.  baumannii  clonal  lineages  I  and  II  isolated
from  burn  wounds  of  burn  patients  are  identi-
cal to  those  isolated  from  hospitalized  patients
F
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n  other  clinical  settings  and  from  other  sources
2,29—31]. The  isolate  belonging  to  international
lone III  was  MDR  and  harbored  genes  for  blaOXA-51-
ike, blaOXA-23-like  +  ISAba1,  blaPER-like,  and  the
deABC efﬂux  pump.  Unlike  other  reports  from
ran, European  countries,  Asia,  and  Latin  America
2,3,9—11,17,28,29], we  did  not  detect  blaOXA-58-
ike carbapenemase  in  our  isolates.  Thus  far,  there
re a  few  reports  are  available  about  microorgan-
sms that  are  the  most  frequently  isolated  from
urn patients  in  Tehran.  Although  Tehran  has  more
han 130  hospitals,  only  a few  specialize  in  the
reatment  of  burns,  and  among  these,  the  Mota-
ari Burn  and  Reconstruction  Center  is  the  largest,
nd its  importance  and  relevance  to  the  treatment
f burns  cannot  be  overstated.  A  glance  at  previ-
us studies  by  us  and  other  researchers  in  Tehran
hows that  gram-negative  bacilli  such  P.  aeruginosa,
lebsiella pneumoniae, and  A.  baumannii  are  fre-
uently isolated  from  clinical  specimens,  especially
rom  wounds,  blood,  and  tracheae,  and  some  genes
lay important  roles  in  the  antimicrobial  resis-
ance developed  to  the  antibiotics  used.  In  these
tudies,  blaOXA carbapenemase,  blaVIM,  blaIMP,  and
laKPC were  introduced  as  major  resistance  genes
ncoding  resistance  to  carbapenems  [8—11,32—35].
wing to  the  status  of  burn  patients  who  are  at
igh risk  for  skin  infection  and  septicemia,  most
f the  bacteria  were  isolated  from  wounds  and/or
lood. However,  from  some  patients  who  were  hos-
italized  in  ICU  wards,  tracheal  samples  were  taken
ecause  of  the  occurrence  of  ventilator-associated
neumonia  [8—11,32—35].
onclusion
ur  data  show  that  A.  baumannii  infections  in
urn patients  in  Iran  were  caused  by  the  spread  of
wo MDR  and  carbapenem-resistant  epidemic  clonal
ineages,  which  were  assigned  to  international
lonal lineages  I  and  II.  The  presence  of  blaOXA-23-
ike and/or  blaOXA-24-like  carbapenemases  might
ave contributed  to  the  establishment  of  the  epi-
emic clones  among  burn  patients.  The  increase  in
nfections caused  by  carbapenem-resistant  A.  bau-
annii in  burn  patients  suggests  the  necessity  for
 surveillance  program  that  involves  monitoring  of
ealth care-associated  infections,  molecular  typ-
ng of  microbial  isolates,  and  characterization  of
ntimicrobial  resistance.unding
o  funding  sources.
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